Skip to main content

Advertisement

SpringerLink
Log in

Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer

  • Published:
Surgical Endoscopy And Other Interventional Techniques Aims and scope Submit manuscript

An Erratum to this article was published on 06 April 2006

Abstract

Background

The authors have previously demonstrated that insulin-like growth factor binding protein-3 (IGFBP-3) is depleted in plasma for 1 to 3 days after major open surgery (OS), but not after laparoscopic surgery (LS). After surgery, IGFP-3 cleavage occurs rapidly and is likely attributable to altered plasma proteolytic activity. This study aimed to assess plasma proteolysis after both open and closed colorectal resection and, if possible, to identify a protease/protease inhibitor system affected by surgery.

Methods

Plasma from 88 patients with colorectal cancer (stages I–III) who underwent resection was obtained preoperatively (pre-OP) and on postoperative days (POD) 1 to 3. Plasma proteolytic activity was assessed via zymography. On the basis of the results, specific protease and protease inhibitor concentrations were next measured via enzyme-linked immunoassay (ELISA). Statistical analysis was performed using Wilcoxon’s test.

Results

Early after surgery, zymography showed a predominant band representing a 92-kDa gelatinase corresponding to a proform of matrix metalloproteinase-9 (MMP-9), a protease known to cleave IGFBP-3. In OS patients, the mean concentration of plasma MMP-9 was significantly higher on POD 1 than at pre-OP (p < 0.003). On POD 2 and 3, no differences were noted. In the LS group, the mean levels of MMP-9 before and after surgery were comparable. The levels of a natural MMP-9 inhibitor, tissue inhibitor of metalloproteinase-1 (TIMP-1), also were measured. In the OS group, the level of TIMP-1 was significantly higher on POD 1 (p < 0.0003) and POD 2 (p < 0.01) and 3 (p < 0.01) than at pre-OP. In the LS group, a smaller but significant increase in TIMP-1 levels was found between the pre-OP sample and the POD 1 (p < 0.01) and POD 2 (p < 0.01) samples. No difference was noted on POD 3 (p = 0.1).

Conclusions

Open surgery, but not laparoscopic surgery, is accompanied by a short-lived significant increase in MMP-9 levels, which likely accounts for the decrease in IGFBP-3 levels observed after OS. The transitory nature of MMP-9 imbalance may be attributable to the increase in TIMP-1 levels postoperatively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Allendorf JD, Bessler M, Kayton ML, Oesterling SD, Treat MR, Nowygrod R, Whelan RL (1995) Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg 130: 649–653

    CAS  PubMed  Google Scholar 

  2. Aparicio T, Kermorgant S, Dessirier V, Lewin MJ, Lehy T (1999) Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis 20: 1445–1451

    Article  CAS  PubMed  Google Scholar 

  3. Dallas SL, Rosser JL, Mundy GR, Bonewald LF (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta )–binding protein-1 by osteoclasts: a cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem. 277: 21352–21360

    Article  CAS  PubMed  Google Scholar 

  4. Descamps FJ, Van den Steen PE, Martens E, Ballaux F, Geboes K, Opdenakker G (2003) Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin. FASEB J 17: 887–889

    CAS  PubMed  Google Scholar 

  5. Dubois B, Peumans WJ, Van Damme EJ, Van Damme J, Opdenakker G (1998) Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins. FEBS Lett 8: 275–278

    Article  CAS  PubMed  Google Scholar 

  6. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H (1994) Matrix metalloproteinases degrade insulin-like growth factor–binding protein-3 in dermal fibroblast cultures. J Biol Chem 269: 25742–25746

    CAS  PubMed  Google Scholar 

  7. Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sorensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brunner N (2002) Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res 8: 156–164

    CAS  PubMed  Google Scholar 

  8. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS (2001) Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7: 3113–3119

    CAS  PubMed  Google Scholar 

  9. Kirman I, Cekic V, Poltaratskaia N, Asi Z, Bessler M, Huang EH, Forde KA, Whelan RL (2002) Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor–binding protein 3 levels may, in part, account for this change. Surgery 132: 186–192

    Article  PubMed  Google Scholar 

  10. Kirman I, Cekic V, Poltoratskaia N, Sylla P, Jain S, Forde KA, Whelan RL (2004) Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery. Surg Endosc 19: 55–59

    PubMed  Google Scholar 

  11. Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW (2001) Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem 276: 20572–20578

    Article  CAS  PubMed  Google Scholar 

  12. Lozonschi L, Sunamura M, Kobari M, Egawa S, Ding L, Matsuno S (1999) Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models. Cancer Res 59: 1252–1258

    CAS  PubMed  Google Scholar 

  13. Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez-AC (1999) The matrix metalloproteinase-9 regulates the insulin-like growth factor–triggered autocrine response in DU-145 carcinoma cells. J Biol Chem 274: 6935–6945

    Article  CAS  PubMed  Google Scholar 

  14. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, Nakamura T, Yamashita S, Matsuzawa Y (2003) Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 108: 1469–1473

    Article  CAS  PubMed  Google Scholar 

  15. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano K (1996) 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65: 57–62

    Article  CAS  PubMed  Google Scholar 

  16. Shankavaram UT, DeWitt DL, Wahl LM (1998) Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2. J Leukoc Biol 64: 221–227

    CAS  PubMed  Google Scholar 

  17. Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH (2001) A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 61: 237–242

    CAS  PubMed  Google Scholar 

  18. Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones C, Schumpelick V (2005) Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 137: 229–234

    Article  PubMed  Google Scholar 

  19. Swallow CJ, Murray MP, Guillem JG (1996) Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin Exp Metastasis 14: 3–11

    CAS  PubMed  Google Scholar 

  20. Takino T, Koshikawa N, Miyamori H, Tanaka M, Sasaki T, Okada Y, Seiki M, Sato H (2003) Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene 22: 4617–4626

    Article  CAS  PubMed  Google Scholar 

  21. Tarlton JF, Vickery CJ, Leaper DJ, Bailey AJ (1997) Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br J Dermatol 137: 506–516

    CAS  PubMed  Google Scholar 

  22. Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TW, Hanemaaijer R (2003) Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 62: 1094–1099

    Article  CAS  PubMed  Google Scholar 

  23. Trocme C, Gaudin P, Berthier S, Barro C, Zaoui P, Morel F (1998) Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem 273: 20677–20684

    Article  CAS  PubMed  Google Scholar 

  24. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, Tsukada K, Saiki I (2003) Increased surgical stress promotes tumor metastasis. Surgery 133: 547–555

    Article  PubMed  Google Scholar 

  25. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G (2003) Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 270: 3739–3749

    Google Scholar 

  26. Ylisirnio S, Hoyhtya M, Makitaro R, Paaakko P, Risteli J, Kinnula VL, Turpeenniemi-Hujanen T, Jukkola A (2001) Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res 7: 1633–1637

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, BB1702, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY, 10032, USA

    I. Kirman, S. Jain, V. Cekic, A. Belizon, E. Balik, P. Sylla, T. Arnell, K. A. Forde & R. L. Whelan

Authors
  1. I. Kirman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Cekic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Belizon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Balik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Sylla
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Arnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. A. Forde
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. L. Whelan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Kirman.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00464-006-3031-7.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirman, I., Jain, S., Cekic, V. et al. Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer. Surg Endosc 20, 482–486 (2006). https://doi.org/10.1007/s00464-005-0222-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-005-0222-6

Keywords

Search

Navigation